ENQUIRY
PAY FEES
ANNOUNCEMENTS
Shri Vile Parle Kelavani Mandal's
INSTITUTE OF PHARMACY, DHULE
Approved by PCI, AICTE, DTE
Affiliated to DBATU, Lonere & MSBTE Mumbai
  (02562) 297802, 297602
  iopdhule@svkm.ac.in  
Shri Vile Parle Kelavani Mandal's
INSTITUTE OF PHARMACY, DHULE
Approved by PCI, New Delhi, DTE, Mumbai, Government of Maharashtra
Affiliated to DBATU, Lonere & MSBTE Mumbai

Accredited in 1st cycle with A+ Grade (CGPA 3.43) by NAAC | Accredited by NBA (Diploma Program)
(02562) 297802, 297602   iopdhule@svkm.ac.in  

FACULTY

Dr. Bhushan R Dravyakar

Associate Professor

Qualification: M. Pharm., Ph.D.

Specialization: Pharmaceutical Chemistry

Email ID: bhushan.dravyakar@svkm.ac.in

Phone:

Experience: 18 Years

Academic

  • Presently working as Associate Professor and Head of Pharmaceutical Chemistry Department at SVKM’s Institute of Pharmacy, Dhule from 15/June/2018.
  • Previously worked as Assistant Professor in Department of Pharmaceutical Chemistry, Dr. Bhanuben Nanavati College of Pharmacy, Mumbai from 15/Jul/2014 to 14/Jun/2022.
  • Also worked as Assistant Professor in Dept. Pharmaceutical Chemistry, at Priyadarshini J. L. College of Pharmacy, Nagpur from 16/Oct/2006 to 14/Jul/2014.

Industry

  • Worked as a Production Officer-II at SUN Pharmaceutical Industries Ltd, Vapi, Gujrat from August, 03rd, 2003 to July, 25th, 2004.

Life member of:

i. Association of Pharmaceutical Teachers of India (APTI)

ii. Medicinal and Aromatic Plant Association of India (MAPAI)

iii. Indian Pharmaceutical Association, India

iv. Indian Society for Technical Education

Interest Areas:

i. Synthetic development & reduction of synthetic routes

ii. Pharmacokinetic studies: Estimation of drug content in biological fluids using UV, HPLC, HPTLC, GC and FTIR.

iii. Molecular Modeling, 3D-QSAR, Docking studies.

Research:

  • Publications:
    • International: 12
    • National: 02
  • Books: Nil
  • Book Chapters: Nil
  • Patents: Nil
  • Copyright: 01
  • Presentations:
    • International: 01
    • National: 14
  • Completed Government Funded Projects: Nil
  • Industry Projects:
    • Completed: 01
    • Ongoing: 01

Conferences/Workshops/Seminars attended: 21

Academic Activities:

  • Ph.D.: Nil
  • Registered: Nil
  • M. Pharm Guided: 03 (as co guide)
  • B. Pharm Guided: 10

Awards: Nil.

Professional Membership: E.g. APTI, IPA, ISTE and MAPAI

Recent Publications: 

1. Design and Development of Novel 2-(Morpholinyl)-N-substituted Phenyl-quinazolin-4-amines as Selective COX-II Inhibitor, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, January 2019, Volume 18, 4-25. (0.32)

2. Bone Health and Natural Products-An Insight, Frontiers in Pharmacology, September 2018, Volume 9, 1-12. (5.81)

3. AP Sherje, M Jadhav, BR Dravyakar, D Kadam; Dendrimers: A versatile nanocarrier for drug delivery and targeting, International Journal of Pharmaceutics 548 (2018) 707–720. (6.51)

4. K Patel, S Butala, T Khan, V Suvarna, A Sherje, B Dravyakar; Mycobacterial siderophore: A review on chemistry and biology of siderophore and its potential as a target for tuberculosis, European Journal of Medicinal Chemistry 157 (2018) 783-790. (6.82)

5. T Khan, K Sankhe, V Suvarna, A Sherje, K Patel, B Dravyakar; DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents, Biomedicine & Pharmacotherapy 103 (2018) 923–938. (7.41)

6. AP Sherje, BR Dravyakar, D Kadam, M Jadhav; Cyclodextrin-based nanosponges: A critical review, Carbohydrate Polymers 173 (2017) 37–49. (9.81)

7. Atul P Sherje, Vaidehi Kulkarni, Manikanta Murahari, Usha Y Nayak, Pritesh Bhat, Vasanti Suvarna, Bhushan Dravyakar; Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies, Molecular Pharmaceutics, 2017;14(4):1231-1242.(4.39)

8. MH Nirajkumar Sinha, Alpana Asnani, Bhushan R; Synthesis and Pharmacological Evaluation of Spiroquinazolinones as Anti- Inflammatory and Analgesic Agents”, Int. J. of Adv. Res., Volume 1, Issue 6, 2013.

9. NK Sinha, AJ Asnani, BR Dravyakar; A novel approach towards development of quinazoline derivatives in pain management”, Asian J Pharm Clin Res, Vol 6, Suppl 3, 2013

10. Study of Synthesis of Novel N, 2-Diphenylquinazolin-4-aminederivatives as an Anti-inflammatory and Analgesic Agent”, Der Pharma Chemica, Vol. 4, Issue 2, 2012.

11. NB Charbe, AP Mehere, SG Shende, VS Mohod, DT Gautam, M Madusudhan, Chaitanya Ch, Dravyakar B; Study of new developments in birch reduction process and their applications for the synthesis and CNS depressant activity of 3-aminocyclohexa-1,4-diene-1-carboxylic acid and 3-[5-substituted-1,3,4-thiadiazole-2-yl]-2-styryl-5,8-dihydro-quinazoline-4(3H)-ones”, Int. J. of Drug Dis., Volume 2, Issue 1, 2010.

12. BR Dravyakar, DP Kawade, PB Khedekar, KP Bhusari Design and syntheses of some new diphenylaminoisoxazolines as potent anti-inflammatory agent” Indian Journal of Chemistry Section B, October, 2008. (0.45)

13. BR Dravyakar, DP Kawade, PB Khedekar, KP Bhusari Review article published in Pharma Review entitled, "Review on Electronic Resources in Pharmaceutical Chemistry” October 2008.

14. BR Dravyakar, DP Kawade, PB Khedekar, KP Bhusari; Synthesis and pharmacological studies of some 6-aminopyrimidin-4-ones’’ Indian Journal of Heterocyclic Chemistry, Vol.16, Jan -March, 2007. (0.33)

Copyright 2024 SVKM's INSTITUTE OF PHARMACY. All Rights Reserved.   Privacy Policy   Terms of Use
Admission Enquiry
Name *
Email *
Mobile *
Query / Comments *